share_log

Needham Reiterates Buy on G1 Therapeutics, Maintains $12 Price Target

Needham Reiterates Buy on G1 Therapeutics, Maintains $12 Price Target

Needham重申买入G1 Therapeutics,维持12美元的目标股价
Benzinga ·  05/28 11:06

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

Needham分析师吉尔·布鲁姆重申G1 Therapeutics(纳斯达克股票代码:GTHX)的买入并维持12美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发